Argyle Capital Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$267K Hold
3,131
– – 0.17% 141
2026
Q2
$287K Hold
3,131
– – 0.18% 137
2026
Q1
$267K Hold
3,131
– – 0.19% 132
2025
Q4
$247K Hold
3,131
– – 0.18% 132
2025
Q3
$250K Hold
3,131
– – 0.18% 140
2025
Q2
$285K Hold
3,131
– – 0.23% 117
2025
Q1
$293K Hold
3,131
– – 0.25% 105
2024
Q4
$285K Buy
+3,131
New +$299K 0.24% 107

Other funds holding CL

Argyle Capital Partners's CL Position: Q3 2026 in Review

Argyle Capital Partners held its Colgate-Palmolive (CL) position steady in Q3 2026 at 3,131 shares worth $267K. The position accounts for 0.17% of the portfolio, ranked #141.

Argyle Capital Partners first reported a position in CL in Q4 2024 and has held it in 8 quarters since. The position peaked at $293K in Q1 2025. 1,142 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Argyle Capital Partners held 3,131 shares of Colgate-Palmolive worth $267K as of Q3 2026.
  • Argyle Capital Partners left its Colgate-Palmolive share count unchanged in Q3 2026.
  • Colgate-Palmolive made up 0.17% of Argyle Capital Partners's portfolio in Q3 2026, its #141 holding.
  • Argyle Capital Partners first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 8 quarters since.
  • Argyle Capital Partners's Colgate-Palmolive position peaked at $293K in Q1 2025.
  • 1,142 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Argyle Capital Partners's 13F filing for Q3 2026, filed 23 Oct 2026.